Margarita  L Dubocovich, PhD
Margarita L Dubocovich, PhD
SUNY Distinguished Professor, Senior Associate Dean, Jacobs School of Medicine, UB (SUNY)
Verified email at
Cited by
Cited by
Functional MT 1 and MT 2 melatonin receptors in mammals
ML Dubocovich, M Markowska
Endocrine 27 (2), 101-110, 2005
Melatonin is a potent modulator of dopamine release in the retina
ML Dubocovich
Nature 306 (5945), 782-784, 1983
Melatonin receptors: are there multiple subtypes?
ML Dubocovich
Trends in pharmacological sciences 16 (2), 50-56, 1995
International Union of Basic and Clinical Pharmacology. LXXV. Nomenclature, classification, and pharmacology of G protein-coupled melatonin receptors
ML Dubocovich, P Delagrange, DN Krause, D Sugden, DP Cardinali, ...
Pharmacological reviews 62 (3), 343-380, 2010
Melatonin-depleted blood from premenopausal women exposed to light at night stimulates growth of human breast cancer xenografts in nude rats
DE Blask, GC Brainard, RT Dauchy, JP Hanifin, LK Davidson, JA Krause, ...
Cancer research 65 (23), 11174-11184, 2005
Molecular pharmacology, regulation and function of mammalian melatonin receptors
ML Dubocovich, MA Rivera-Bermudez, MJ Gerdin, MI Masana
Front Biosci 8 (10), 1093-108, 2003
High-affinity [3H] imipramine binding in rat hypothalamus: association with uptake of serotonin but not of norepinephrine
SZ Langer, C Moret, R Raisman, ML Dubocovich, M Briley
Science 210 (4474), 1133-1135, 1980
Selective MT2 melatonin receptor antagonists block melatonin‐mediated phase advances of circadian rhythms
ML Dubocovich, K Yun, WM Al‐Ghoul, S Benloucif, MI Masana
The FASEB Journal 12 (12), 1211-1220, 1998
Pharmacology and function of melatonin receptors
ML Dubocovich
The FASEB journal 2 (12), 2765-2773, 1988
The impact of school daily schedule on adolescent sleep
M Hansen, I Janssen, A Schiff, PC Zee, ML Dubocovich
Pediatrics 115 (6), 1555-1561, 2005
Melatonin receptor antagonists that differentiate between the human Mel1a and Mel1b recombinant subtypes are used to assess the pharmacological profile of the rabbit retina ML1 …
ML Dubocovich, MI Masana, S Iacob, DM Sauri
Naunyn-Schmiedeberg's archives of pharmacology 355 (3), 365-375, 1997
Activation of MT2 melatonin receptors in rat suprachiasmatic nucleus phase advances the circadian clock
AE Hunt, WM Al-Ghoul, MU Gillette, ML Dubocovich
American Journal of Physiology-Cell Physiology 280 (1), C110-C118, 2001
Melatonin receptors: role on sleep and circadian rhythm regulation
ML Dubocovich
Sleep medicine 8, 34-42, 2007
Use of 2-[125I] iodomelatonin to characterize melatonin binding sites in chicken retina
ML Dubocovich, JS Takahashi
Proceedings of the National Academy of Sciences 84 (11), 3916-3920, 1987
MT1 and MT2 Melatonin Receptors: A Therapeutic Perspective
J Liu, SJ Clough, AJ Hutchinson, EB Adamah-Biassi, ...
Annual review of pharmacology and toxicology 56, 361-383, 2016
Luzindole (N-0774): a novel melatonin receptor antagonist.
ML Dubocovich
Journal of Pharmacology and Experimental Therapeutics 246 (3), 902-910, 1988
Negative feedback regulation of noradrenaline release by nerve stimulation in the perfused cat's spleen: differences in potency of phenoxybenzamine in blocking the pre‐and post …
ML Dubocovich, SZ Langer
The Journal of physiology 237 (3), 505-519, 1974
Melatonin mediates two distinct responses in vascular smooth muscle
S Doolen, DN Krause, ML Dubocovich, SP Duckles
European journal of pharmacology 345 (1), 67-69, 1998
The concise guide to pharmacology 2017/18: overview
SPH Alexander, E Kelly, NV Marrion, JA Peters, E Faccenda, SD Harding, ...
British journal of pharmacology 174, S1-S16, 2017
Melatonin receptor signaling: finding the path through the dark
MI Masana, ML Dubocovich
Science's STKE 2001 (107), pe39-pe39, 2001
The system can't perform the operation now. Try again later.
Articles 1–20